Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18,580,860
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
8,355,176
-
Shares change
-
+690,328
-
Total reported value, excl. options
-
$85,802,427
-
Value change
-
+$5,161,402
-
Number of buys
-
25
-
Number of sells
-
-31
-
Price
-
$10.27
Significant Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q4 2019
71 filings reported holding OPRX - OptimizeRx Corp - Common Stock as of Q4 2019.
OptimizeRx Corp - Common Stock (OPRX) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,355,176 shares
of 18,580,860 outstanding shares and own 45% of the company stock.
Largest 10 shareholders include AWM Investment Company, Inc. (952,027 shares), BlackRock Inc. (938,436 shares), Park West Asset Management LLC (814,668 shares), VANGUARD GROUP INC (658,708 shares), G2 Investment Partners Management LLC (658,277 shares), WASATCH ADVISORS INC (605,857 shares), WOLVERINE ASSET MANAGEMENT LLC (591,073 shares), AVENIR CORP (588,402 shares), P.A.W. CAPITAL CORP (285,000 shares), and STATE STREET CORP (238,909 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.